Macrocyclics
Macrocyclics 專業致力于生產用于核醫學和醫學成像的定制的螯合劑。我們為客戶定制用于臨床試驗并且符合 cGMP（動態藥品生產管理規范）標準的產品，我們提供生物偶聯服務和咨詢服務以便幫助客戶選擇適合其特定需求的同位素。
MACROCYCLICS 簡介
從1995年開始 Macrocyclics 就成為了為醫學提供高性能螯合劑技術的全球***。Macrocyclics 的團隊致力于為客戶提供發展成熟和富有**的螯合劑與服務，幫助應對分子成像和核醫學方面的挑戰。
AREVA MED 簡介
AREVA Med 是阿?，m (AREVA) 下屬公司，專門從事富有**精神的****產品的開發。AREVA Med 為生產高純度鉛-212 (212Pb) 開發了新工藝，這種稀有金屬目前在發展前景良好的核醫學研究領域處于核心地位。2011年，AREVA Med 收購了全球高性能螯合劑技術*** Macrocyclics。AREVA Med 還和美國國家癌癥研究所 (NCI)、阿拉巴馬大學伯明翰分校 (UAB) 及法國國家健康與醫學研究院 (Inserm) 等***科學合作伙伴開展合作。2012年，AREVA Med 和羅氏 (Roche) 達成了戰略聯盟，以便共同創造全新、先進的阿爾法放射****技術來鎖定和消滅某些侵襲性特別強的癌癥細胞。
Macrocyclics 產品列表：
Macrocyclics 雙功能配體
p-SCN-Bn-TCMC
p-NO2-Bn-Cyclen
p-NO2-Bn-DOTA
p-NH2-Bn-DOTA
p-NH2-Bn-DOTA-tetra(t-Bu-ester)
p-SCN-Bn-DOTA
DOTA-tris (t-Bu ester)
DOTA-mono-NHS-tris(t-Bu ester)
Maleimido-mono-amide-DOTA-tris (t-Bu ester)
Maleimido-mono-amide-DOTA B-272
Fmoc-L-Lys-mono-amide-DOTA-tris(t-Bu ester)
2-Aminoethyl-mono-amide-DOTA-tris(t-Bu ester)
Azido-mono-amide-DOTA-tris(t-butyl ester)
DOTA-NHS-ester
Azido-mono-amide-DOTA
p-NH2-Bn-DTPA
p-NH2-Bn-DTPA-penta (t-Bu ester)
p-SCN-Bn-DTPA
p-NH2-CHX-A"-DTPA
CHX-A''-DTPA
DTPA-tetra (t-Bu ester)
Maleimido-mono-amide-DTPA
p-NH2-Bn-PCTA
p-SCN-Bn-PCTA
p-NH2-Bn-oxo-DO3A
p-SCN-Bn-oxo-DO3A
p-NH2-Bn-NOTA
p-SCN-Bn-NOTA
Deferoxamine-p-SCN
Deferoxamine-maleimide
DOTA-Biotin-Sarcosine
Samplet Pack- Bifunctionals
Macrocyclics 大環配體
Cyclam
DO2A
DOTA
DOTP
DOTMA
TETA
DOTAM
DiAmSar
CB-Cyclam
CB-TE2A
NOTA
TACN
Macrocyclics 造影劑
Tm-DOTA
Gd-DOTA
Tm[DOTP]5-
Tm-DOTMA
Eu-DOTA-4AmC
Macrocyclics 中間體
BisCBZ-Cyclen
TrisBOC-Cyclen
DO2A-t-Bu-ester
DO3A-t-Bu-ester
-
Bifunctional Chelators (BFCs) -
Conjugates -
Fluorescent Probes -
Macrocyclic Ligands -
Magnetic Resonance Reagents -
Reactive Intermediates
About the company Macrocyclics
Macrocyclics, Inc., a manufacturer of customized chelating agents, is dedicated to leading-edge development of new chelation chemistry platforms critical for advancement of diagnostic and therapeutic medicine.
Macrocyclics offers a large number of services in different areas.
Macrocyclics is operating in a brand new facility equipped with state of the art chemistry and biological laboratories as well as a radio-chemistry lab licensed to include all of the most popular radionuclides for PET imaging and therapeutic applications.
Our new facility was designed to expand our cGMP custom synthesis and bioconjugations services. New and improved capabilities include peptide synthesis, a dedicated radio-isotope hot-lab and two new analytical laboratories with UPLC, QTOF, CE, FTIR, polarimeter.
-
Bioconjugation Services -
cGMP Services -
